159 related articles for article (PubMed ID: 3258143)
1. In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.
Quentin R; Koubaa N; Cattier B; Gavignet M; Goudeau A
Antimicrob Agents Chemother; 1988 Jan; 32(1):147-9. PubMed ID: 3258143
[TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
Van der Auwera P
Infection; 1986; 14(3):142-4. PubMed ID: 2942489
[TBL] [Abstract][Full Text] [Related]
5. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
7. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Delmee M; Avesani V
Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Edlund C; Nord CE
Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556
[TBL] [Abstract][Full Text] [Related]
10. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
Davies S; Sparham PD; Spencer RC
J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
Barry AL; Jones RN
Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
[TBL] [Abstract][Full Text] [Related]
12. The comparative in-vitro activity of pefloxacin.
King A; Phillips I
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
[TBL] [Abstract][Full Text] [Related]
13. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
14. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
Habiyaremye I; Verbist L; Vandepitte J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
[TBL] [Abstract][Full Text] [Related]
15. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
Berlin OG; Young LS; Bruckner DA
J Antimicrob Chemother; 1987 May; 19(5):611-5. PubMed ID: 3112095
[TBL] [Abstract][Full Text] [Related]
16. [New oral quinolone compounds in chronic bronchitis].
Davies BI; Maesen FP; Teengs JP; Baur C
Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
[TBL] [Abstract][Full Text] [Related]
17. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
King A; Shannon K; Phillips I
J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
[TBL] [Abstract][Full Text] [Related]
18. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Dabernat H; Delmas C; Lareng MB
Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of A-56619 and A-56620, two new quinolones.
Barry AL; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
[TBL] [Abstract][Full Text] [Related]
20. A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.
Edlund C; Nord CE
Infection; 1988; 16(1):8-12. PubMed ID: 3283041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
